MILAN, Italy – September 16, 2022 – Olon is pleased to announce the appointment of Roberta Pachera as Vice President of CDMO Small Molecules and Global Key Account Division. The appointment is effective from the 12th of September.
Roberta joins Olon with two decades of experience in the global pharmaceutical industry, including senior positions at GlaxoSmithKline, Aptuit, and F.I.S. She also brings a wealth of international experience, having previously held roles in US and UK. Most recently Roberta served as VP, Global Head of Custom Synthesis at PharmaZell Group.
Over her professional pathway, Roberta has implemented commercial strategies for international markets, she has created opportunities in the pharma market that have developed the CDMO business while expanding the baseline client. She has developed strong operational competencies covering multiple responsibilities within the Chemical Development Organization.
Roberta takes over the leadership CDMO Small Molecules and Global Key Accounts to lead the continuous expansion and growth of the Group, pursuing new business opportunities in the CDMO pharma space. The business unit, relying on one of the broadest and deep expertise in the chemical synthesis process, oversees developing new business opportunities based on chemistry process manufacturing further than running the ongoing projects.
Paolo Tubertini, CEO of Olon, commented: “Roberta’s expertise in leading cross-functional teams will take our diverse offerings within Small Molecules into a new stage of growth and development."
Roberta has a University Degree in Organic Chemistry at the University of Bologna and has successfully concluded a degree at CUOA Business School in collaboration with the School of Management, University of Michigan.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Olon is an Italian company world leader in the Active Pharmaceutical Ingredients (APIs) production, using synthetic and biological processes for the Generic market as well as in Contract Development and Manufacturing (CDMO). Headquartered in Rodano (Italy), Olon has 11 manufacturing facilities – 8 located in Italy, 1 in Spain, 1 in USA and 1 in India, all compliant with international requirements, and 3 branch offices. Olon offers complete integrated packages and services to support the full development of APIs based on strong knowledge in both, Chemical and Biological processes, in a full cGMPs environment including complete regulatory coverage.